A Phase 1b/III study of Ipatasertib plus Palbociclib and Fulvestrant versus placebo plus Palbociclib and Fulvestrant in hormone receptor positive and Her2 negative locally advanced unresectable or metastatic breast cancer [Ipatunity150] [CO41012]

  • Antill, Yoland (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)
  • Thompson, Katherine (Project Manager)

Project: Research

Project Details

Effective start/end date13/02/2031/12/25


  • Medical Oncology
  • Breast cancer
  • Clinical trial